Trichomonas vaginalis Legumain-2, TvLEGU-2, Is an Immunogenic Cysteine Peptidase Expressed during Trichomonal Infection [PDF]
Trichomonas vaginalis is the causative agent of trichomoniasis, the most prevalent nonviral, neglected sexually transmitted disease worldwide. T. vaginalis has one of the largest degradomes among unicellular parasites.
Esly Alejandra Euceda-Padilla +8 more
doaj +3 more sources
Nifuratel (Magmilor) in Trichomonal Vaginitis. [PDF]
Introduced almost adecade ago,Flagyl (Metronidazole) isstill theonlyacceptable systemic therapy available fortrichomoniasis. Fortunately, theefficacy ofFlagyl hasremained ataveryhighlevel andthere isnoevidence thatTrichomonas vaginalis hasdeveloped, orisdeveloping, anyresistance toit. However, there hasalways beentheoccasional case inwhichevenverylarge
W Fowler
exaly +5 more sources
Bacterial vaginosis, vulvovaginal candidiasis and trichomonal vaginitis among reproductive-aged women seeking primary healthcare in Sana’a city, Yemen [PDF]
Background In Yemen, the underlying causes of infectious vaginitis have been neglected. Therefore, this study aimed to determine the prevalence and risk factors associated with bacterial vaginosis (BV), vulvovaginal candidiasis (VVC) and trichomonal ...
Maha Abdul-Aziz +11 more
doaj +2 more sources
Associations between vaginal microecological status and high-risk human papillomavirus positivity in women from Eastern China: a retrospective cross-sectional study [PDF]
BackgroundEvidence regarding the associations between vaginal microecological status and high-risk human papillomavirus (hrHPV) genotype categories remains limited, particularly in large-sample studies.
Junxia Wang +7 more
doaj +2 more sources
The correlation between vaginal pathogens and high-risk human papilloma virus infection: a meta-analysis of case-control studies [PDF]
BackgroundSystematic study on the relationship between vaginal microbiota and high-risk human papillomavirus infection (HR-HPV) is limited. Hence, the aim of this study is to investigate the correlation between vaginal microbiota and HR-HPV infection ...
Jun Yang +11 more
doaj +2 more sources
Objectives To investigate changes in vaginal microecology in women with high-risk human papillomavirus (HR-HPV) infection after focused ultrasound (FU) treatment.Materials and methods We collected vaginal secretions at the time of admission and 3 months ...
Hua Tao +11 more
doaj +2 more sources
Nifuratel Compared With Metronidazole in the Treatment of Trichomonal Vaginitis [PDF]
Nifuratel (Magmilor) was compared with metronidazole (Flagyl) in the treatment of trichomonal vaginitis by a randomized double-blind trial. Only 18 out of 47 patients (38%) treated with nifuratel were found to be cured, whereas 42 out of 49 patients (85%) treated with metronidazole were cured.
B A Evans, R D Catterall
exaly +3 more sources
Trichomonal vaginitis refractory to conventional treatment. [PDF]
Seligman SA.
europepmc +7 more sources
The current study aims to determine the prevalence of Trichomonas vaginalis and Candida spp., and also to identify Candida parapsilosis and some virulence genes.
Enas R. Alwaily +3 more
doaj +1 more source

